The Australian manufacturing sector is contracting further, as evidenced by the Ai Group Industry Index falling to -29.3, ...

Yext's bottom line is improving, but organic growth remains challenged. Click here to see why YEXT stock is a Hold.

Kura Oncology's ziftomenib shows promise in AML treatment, with FDA Priority Review ahead. Read here for an analysis of KURA ...

Archer-Daniels-Midland navigates challenges like weak soybean margins and trade tensions with cost cuts and diversification.

Overweight position in the CMBS sector, particularly the AAA Agency subcomponent, was accretive to the NYLI Short Term Bond ...

Meta's AI investments, open-source strategy, and Zuckerberg's bold vision position it as a leader against OpenAI & Google.

Thrivent Mid Cap Value Fund underperformed its benchmark, Russell Midcap Value Index, during the quarter driven by negative stock selection. Performance was negative in 6 out of 11 sectors led by ...

Transocean's declining backlog impacts revenue, investor sentiment, and share price potential. See here to know why we are ...

Healthcare Realty offers a 7-8% yield but faces rate pressures and tight dividend coverage. Learn why stabilization and ...

Whitecap Resources' acquisition of Veren enhances diversification, synergies, and efficiency. Read here for more analysis of ...

BlueLinx focuses on high-margin growth via specialty products and acquisitions. The current valuation is attractive, versus ...

Wolfspeed's shares soared 100% post-bankruptcy filing, but risks loom with potential delisting. See here to know why experts ...